RhoA induces expression of inflammatory cytokine in adipocytes.

[1]  野崎 真衣子.  Nitric oxide dysregulates adipocytokine expression in 3T3-L1 adipocytes , 2009 .

[2]  H. Kaufman,et al.  Activation of Rho Kinase by TNF-α Is Required for JNK Activation in Human Pulmonary Microvascular Endothelial Cells1 , 2008, The Journal of Immunology.

[3]  S. Lavandero,et al.  Rho Kinase Activation and Gene Expression Related to Vascular Remodeling in Normotensive Rats With High Angiotensin I–Converting Enzyme Levels , 2007, Hypertension.

[4]  T. Wandless,et al.  A Directed Approach for Engineering Conditional Protein Stability Using Biologically Silent Small Molecules* , 2007, Journal of Biological Chemistry.

[5]  G. Nixon,et al.  Spatial Compartmentalization of Tumor Necrosis Factor (TNF) Receptor 1-dependent Signaling Pathways in Human Airway Smooth Muscle Cells , 2006, Journal of Biological Chemistry.

[6]  L. Gleaves,et al.  Bone Marrow Plasminogen Activator Inhibitor-1 Influences the Development of Obesity* , 2006, Journal of Biological Chemistry.

[7]  L. Banaszynski,et al.  A Rapid, Reversible, and Tunable Method to Regulate Protein Function in Living Cells Using Synthetic Small Molecules , 2006, Cell.

[8]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[9]  Y. Matsuzawa.  The metabolic syndrome and adipocytokines , 2006, FEBS letters.

[10]  A. Xu,et al.  Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. , 2006, Biochemical and biophysical research communications.

[11]  S. Atkinson,et al.  Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. , 2005, Kidney international.

[12]  Young-Bum Kim,et al.  Role of Rho-kinase in regulation of insulin action and glucose homeostasis. , 2005, Cell metabolism.

[13]  P. Trayhurn.  Endocrine and signalling role of adipose tissue: new perspectives on fat. , 2005, Acta physiologica Scandinavica.

[14]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[15]  Morihiro Matsuda,et al.  Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.

[16]  R. Paschke,et al.  Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. , 2004, Biochemical and biophysical research communications.

[17]  Christopher S. Chen,et al.  Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. , 2004, Developmental cell.

[18]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[19]  M. Matsuda,et al.  Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.

[20]  J. Settleman,et al.  Modulation of Rho GTPase Signaling Regulates a Switch between Adipogenesis and Myogenesis , 2003, Cell.

[21]  P. Vandenabeele,et al.  Tumor necrosis factor-alpha-induced activation of RhoA in airway smooth muscle cells: role in the Ca2+ sensitization of myosin light chain20 phosphorylation. , 2003, Molecular pharmacology.

[22]  H. Neumann,et al.  Tumor Necrosis Factor Inhibits Neurite Outgrowth and Branching of Hippocampal Neurons by a Rho-Dependent Mechanism , 2002, The Journal of Neuroscience.

[23]  M. Crow,et al.  Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[24]  H. Lijnen.  Elements of the Fibrinolytic System , 2001, Annals of the New York Academy of Sciences.

[25]  B. Binder,et al.  Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[26]  W. Kiosses,et al.  Regulation of the small GTP‐binding protein Rho by cell adhesion and the cytoskeleton , 1999, The EMBO journal.

[27]  L. Cowsert,et al.  Interleukin-1 beta and reactive oxygen species mediate activation of c-Jun NH2-terminal kinases, in human epithelial cells, by two independent pathways. , 1998, Biochemical and biophysical research communications.

[28]  J. Sadoshima,et al.  Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. , 1998, Circulation research.

[29]  K. Kaibuchi,et al.  Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail Association , 1998, The Journal of cell biology.

[30]  B. Rollins.  Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. , 1996, Molecular medicine today.

[31]  B. Sobel,et al.  TNF- a and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes , 1999 .

[32]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[33]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.